| |
| |
|
| Insider
Information: |
Schleifer Leonard S |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
466,877 |
|
|
Indirect Shares
|
227,682 |
|
|
| Direct
Value |
$467,684,697 |
|
|
|
Indirect Value
|
$228,075,890 |
|
|
| Total
Shares |
694,559 |
|
|
| Total
Value |
$695,760,587 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-06-06 |
466,877 |
2024-06-06 |
227,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
CEO & President |
• • – |
2011-09-06 |
4 |
A |
$0.00 |
$0 |
I/I |
7,000 |
7,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
CEO & President |
• • – |
2013-09-09 |
4 |
A |
$0.00 |
$0 |
I/I |
5,000 |
5,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2015-01-02 |
4 |
A |
$0.00 |
$0 |
I/I |
1,500 |
1,500 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-03-06 |
4 |
AS |
$18.00 |
$12,600 |
D/D |
(700) |
122,066 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-03-07 |
4 |
AS |
$18.00 |
$7,218 |
D/D |
(401) |
121,665 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-09-13 |
4/A |
AS |
$16.50 |
$262,783 |
D/D |
(15,900) |
91,665 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-09-13 |
4 |
AS |
$16.52 |
$232,921 |
D/D |
(14,100) |
94,758 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-10-17 |
4 |
AS |
$18.00 |
$540,067 |
D/D |
(30,000) |
61,665 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-11-07 |
4 |
AS |
$23.00 |
$1,248,296 |
D/D |
(53,986) |
61,665 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2009-09-13 |
4 |
AS |
$16.50 |
$262,783 |
D/D |
(15,900) |
91,665 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
CEO & President |
• • – |
2011-09-06 |
4 |
AS |
$63.01 |
$521,631 |
I/I |
(7,900) |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2012-05-01 |
4 |
AS |
$133.86 |
$13,482,553 |
D/D |
(100,000) |
286,328 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-03-05 |
4 |
AS |
$175.21 |
$3,354,571 |
D/D |
(19,146) |
222,941 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-03-06 |
4 |
AS |
$175.28 |
$12,101,570 |
D/D |
(69,003) |
153,938 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-03-07 |
4 |
AS |
$175.13 |
$618,909 |
D/D |
(3,534) |
150,404 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-03-13 |
4 |
AS |
$175.01 |
$815,897 |
D/D |
(4,662) |
145,742 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-03-19 |
4 |
AS |
$175.02 |
$639,698 |
D/D |
(3,655) |
142,087 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-05-01 |
4 |
AS |
$225.01 |
$23,765,289 |
D/D |
(100,000) |
42,087 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
CEO & President |
• • – |
2013-09-09 |
4 |
AS |
$275.04 |
$1,377,332 |
I/I |
(5,000) |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-09-19 |
4 |
AS |
$300.33 |
$31,159,181 |
D/D |
(102,949) |
42,087 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-10-02 |
4 |
AS |
$312.44 |
$2,875,253 |
D/D |
(9,162) |
42,087 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2014-10-28 |
4 |
AS |
$400.52 |
$27,921,806 |
D/D |
(69,112) |
91,357 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2014-11-11 |
4 |
AS |
$400.00 |
$1,397,200 |
D/D |
(3,493) |
84,411 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2014-11-12 |
4 |
AS |
$400.22 |
$16,943,285 |
D/D |
(42,324) |
42,087 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2015-01-02 |
4 |
AS |
$408.64 |
$615,867 |
I/I |
(1,500) |
0 |
0 |
- |
|
90 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
